BioCorRx (BICX) Debt to Equity (2016 - 2025)
BioCorRx (BICX) has disclosed Debt to Equity for 11 consecutive years, with -$1.85 as the latest value for Q3 2025.
- Quarterly Debt to Equity fell 1723.01% to -$1.85 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$1.85 through Sep 2025, down 1723.01% year-over-year, with the annual reading at -$0.01 for FY2024, 94.16% up from the prior year.
- Debt to Equity hit -$1.85 in Q3 2025 for BioCorRx, down from -$0.01 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.01 in Q4 2024 to a low of -$1.85 in Q3 2025.
- Historically, Debt to Equity has averaged -$0.37 across 5 years, with a median of -$0.1 in 2024.
- Biggest five-year swings in Debt to Equity: surged 97.32% in 2021 and later crashed 1723.01% in 2025.
- Year by year, Debt to Equity stood at -$0.02 in 2021, then soared by 40.8% to -$0.01 in 2022, then tumbled by 1014.87% to -$0.1 in 2023, then skyrocketed by 94.16% to -$0.01 in 2024, then plummeted by 31387.83% to -$1.85 in 2025.
- Business Quant data shows Debt to Equity for BICX at -$1.85 in Q3 2025, -$0.01 in Q4 2024, and -$0.1 in Q3 2024.